Class of 2007 AbstractObjectives: To investigate the relationship of price and prevalence of statins when new mediations enter the market and when old medications are withdrawn from the market. Methods: Patients that received a statin were enrolled in the Medicare Current Beneficiary Survey (MCBS) from 1992 to 2002. The overall prevalence of each statin as well as the prevalence of each statin for a patient’s drug coverage (no coverage, Medicaid, Medigap, employer coverage, or other public coverage) were analyzed. Results: The overall prevalence of statin was statistically significant for 1992 versus 2002 (p<0.001). When atorvastatin came to the market towards the end of 1996, there was no difference between simvastatin (p=0.24) and pravast...
textStatins are commonly used for treating the elevation of lipids in the blood stream, also known a...
Our objective is to estimate the extent to which clinical and non-clinical factors are associated wi...
We study the evolution of statin consumption between 2005-2017 in the Italian region Emilia-Romagna....
To examine HMG-CoA reductase inhibitor (statin) drug dispensing patterns to Nova Scotia Seniors' Pha...
Abstract Background In 2011, Manitoba implemented a province-wide program of physician detailing and...
<div><p>Purpose</p><p>To examine HMG-CoA reductase inhibitor (statin) drug dispensing patterns to No...
What is already known about this subject • Use of statins is growing worldwide and costs represent a...
The objective of this study was to evaluate the intended and unintended impact on pharmaceutical use...
Background The use of statins has increased substantially over the last 2 decades in England and re...
The objective of this study was to evaluate the intended and unintended impact on pharmaceutical use...
Objectives: Previous Australian research has shown that following the 21% increase in patient co-pay...
Background The use of statins has increased substantially over the last 2 decades in England and re...
Background: Statins have been effective medications in lowering serum total cholesterol (TC) concent...
OBJECTIVE: To compare the risk of cardiovascular-related hospitalization, statin adherence, and dire...
Objective: Statins have been commonly used to treat patients with hypercholesterolaemia and to preve...
textStatins are commonly used for treating the elevation of lipids in the blood stream, also known a...
Our objective is to estimate the extent to which clinical and non-clinical factors are associated wi...
We study the evolution of statin consumption between 2005-2017 in the Italian region Emilia-Romagna....
To examine HMG-CoA reductase inhibitor (statin) drug dispensing patterns to Nova Scotia Seniors' Pha...
Abstract Background In 2011, Manitoba implemented a province-wide program of physician detailing and...
<div><p>Purpose</p><p>To examine HMG-CoA reductase inhibitor (statin) drug dispensing patterns to No...
What is already known about this subject • Use of statins is growing worldwide and costs represent a...
The objective of this study was to evaluate the intended and unintended impact on pharmaceutical use...
Background The use of statins has increased substantially over the last 2 decades in England and re...
The objective of this study was to evaluate the intended and unintended impact on pharmaceutical use...
Objectives: Previous Australian research has shown that following the 21% increase in patient co-pay...
Background The use of statins has increased substantially over the last 2 decades in England and re...
Background: Statins have been effective medications in lowering serum total cholesterol (TC) concent...
OBJECTIVE: To compare the risk of cardiovascular-related hospitalization, statin adherence, and dire...
Objective: Statins have been commonly used to treat patients with hypercholesterolaemia and to preve...
textStatins are commonly used for treating the elevation of lipids in the blood stream, also known a...
Our objective is to estimate the extent to which clinical and non-clinical factors are associated wi...
We study the evolution of statin consumption between 2005-2017 in the Italian region Emilia-Romagna....